Gabriele Ricci

Gabriele Ricci discloses dealings in Takeda Pharmaceutical Co Ltd to SEC (Form 4). Between 27 April 2026 and 10 August 2026, the trades on record add up to 3 filings.

Every open-market trade on record is a sale: 1 sale worth €371k. Outside the open market, there are 2 share grants.

The latest filing, published on 12 August 2026, reports an open-market sale of €371k in Takeda Pharmaceutical Co Ltd. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.